

Past Event
9:00 am - 5:00 pm EDT
1775 Massachusetts Ave., NW
Washington, DC
Three years ago, the U.S. Food and Drug Administration (FDA) launched the Sentinel Initiative, making significant progress in developing a system for conducting active surveillance of medical products. On September 26-27, the Engelberg Center hosted an event to reflect on the progress of the Initiative to date, and to consider its future direction and sustainability.
This event brought together a diverse set of stakeholders to reflect on the progress of the Initiative made to date, and consider its future direction to ensure sustainability of the system and reliability of results generated, including:
Thomas Buchmueller, Helen Levy
May 1, 2025
Richard G. Frank, Fiona Scott Morton, Aaron Kesselheim, Gerard F. Anderson, Rena M. Conti, David M. Cutler, Jack Hoadley
April 30, 2025
Matthew Fiedler
April 30, 2025